This study illustrates the physiological significance of phosphate regulation by IP6K in vivo and provides a novel strategy to treat hyperphosphataemia and the associated complications using IP6K inhibitor-mediated suppression of cellular phosphate export (Fig. 7). The gene discussed is PPIP5K1; the disease is hyperphosphatemia.